Inflammation of actinic keratoses with capecitabine therapy for colon cancer

European Journal of Dermatology

Volumn 18, Issue 2, 2008, Pages 200-

  Vieira Serrão, Vasco ^a   Barata Feio, Ana ^a  

^a HOSPITAL DOS CAPUCHOS   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE;

ACTINIC KERATOSIS; AGED; ANAMNESIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CAUCASIAN; ERYTHEMA; FACE; FOOT SOLE; HAND FOOT SYNDROME; HAND PALM; HUMAN; LETTER; MALE; PAIN; RECTUM CARCINOMA; SCALP; SKIN EXAMINATION; SKIN INFLAMMATION; SYSTEMIC THERAPY; TREATMENT DURATION;

ADENOCARCINOMA; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; DIAGNOSIS, DIFFERENTIAL; FACE; FLUOROURACIL; HUMANS; KERATOSIS; MALE; PRODRUGS; RECTAL NEOPLASMS; SCALP;

EID: 42349092515     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0370     Document Type: Letter

References (6)

1. Hwang JJ, Marshall JL. Capecitabine: fulfilling the promise of oral chemotherapy. Expert Opin Pharmacother 2002; 3: 733-43.
2. Stockfleth E, Kerl H; Guideline Subcommittee of the European Dermatology Forum. Guidelines for the management of actinic keratoses. Eur J Dermatol 2006; 16: 599-606.
3. de Berker D, McGregor JM, Hughes BR; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol 2007; 156: 222-30.
4. Janusch M, Fischer M, Marsch WC, et al. The hand-foot syndrome - a frequent secondary manifestation in antineoplastic chemotherapy. Eur J Dermatol 2006; 16: 494-9.
5. Lewis KG, Lewis MD, Robinson-Bostom L, Pan TD. Inflammation of actinic keratoses during capecitabine therapy. Arch Dermatol 2004; 140: 367-8.
6. Higa GM, Kovach RF, Abraham J. Actinic keratosis and capecitabine therapy. J Oncol Pharm Pract 2005; 11: 151-3.